Premium
Extending the Use of Atezolizumab and Bevacizumab to a Liver Transplant Recipient: Need for a Posttransplant Registry
Author(s) -
Ben Khaled Najib,
Roessler Daniel,
Reiter Florian P.,
Seidensticker Max,
Guba Markus,
De Toni Enrico N.
Publication year - 2021
Publication title -
liver transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.814
H-Index - 150
eISSN - 1527-6473
pISSN - 1527-6465
DOI - 10.1002/lt.26011
Subject(s) - medicine , atezolizumab , bevacizumab , reimbursement , oncology , nivolumab , immunotherapy , cancer , chemotherapy , health care , economics , economic growth
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom